A potential immunopathogenic role for reduced IL-35 expression in allergic asthma

Journal of Asthma

Volumn 52, Issue 8, 2015, Pages 763-771

  Wang, Wei ^a   Li, Ping ^a   Chen, Yi Fei ^a   Yang, Jiong ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Allergic asthma; CD4+CD25 T cells; IL 35; IL 4; proliferative responses

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 35; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; CYTOKINE; PROTEIN SUBUNIT;

ADULT; ALLERGIC ASTHMA; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNOPATHOGENESIS; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAGNETIC SEPARATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE; ASTHMA; BLOOD; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN SUBUNIT;

ADULT; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; FEMALE; HUMANS; MALE; PROTEIN SUBUNITS; RNA, MESSENGER;

EID: 84940651752     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2015.1038390     Document Type: Article

References (32)

1. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), 2014. Available from: www. ginasthma. org.
2. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546-3556.
3. Kay AB. The role of T lymphocytes in asthma. Chem Immunol Allergy 2006;91:59-75.
4. Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010;151:297-307.
5. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy 2011;66: 989-998.
6. Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy 2009;39:1314-1323.
7. Kearley J, Barker JE, Robinson DS, Lloyd CM. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+regulatory T cells is interleukin 10 dependent. J Exp Med 2005;202:1539-1547.
8. Kearley J, Robinson DS, Lloyd CM. CD4+CD25 +regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 2008;122: 617-624 e616.
9. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008;8:523-532.
10. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007;450:566-569.
11. Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol 2012;13:722-728.
12. Liu JQ, Liu Z, Zhang X, Shi Y, Talebian F, Carl Jr JW, Yu C, et al. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 2012;188:3099-3106.
13. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010;11:1093-1101.
14. Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW. IL-35 stimulation of CD39+regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 2010;184:7144-7153.
15. Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, Chua KY. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 2011;187:462-471.
16. Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 2012;129:207-215 e201-205.
17. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43: 343-373.
18. Strauss L, Bergmann C, Gooding W, Johnson JT, Whiteside TL. The frequency and suppressor function of CD4+CD25 highFoxp3+T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2007;13: 6301-6311.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
20. Liu F, Tong F, He Y, Liu H. Detectable expression of IL-35 in CD4+T cells from peripheral blood of chronic hepatitis B patients. Clin Immunol 2011;139:1-5.
21. Cui G, Goll R, Olsen T, Steigen SE, Husebekk A, Vonen B, Florholmen J. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum. Cancer Immunol Immunother 2007;56:985-995.
22. Chen X, Gao YD, Yang J. Elevated interferon regulatory factor 4 levels in patients with allergic asthma. J Asthma 2012; 49:441-449.
23. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008;454:445-454.
24. Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007;37: 3021-3029.
25. Ouyang YH, Nakao A, Fan EZ, Li Y, Zhao LP, Zhang W, Han DM, Zhang L. Decreased expression of EBI3 and Foxp3 in CD4+CD25+regulatory T cells in murine experimental allergic rhinitis. Orl J Oto-Rhino-Lary Relat Spec 2011;73:313-320.
26. Bai J, Qiu SL, Zhong XN, Huang QP, He ZY, Zhang JQ, Liu GN, et al. Erythromycin enhances CD4+Foxp3+regulatory T-cell responses in a rat model of smoke-induced lung inflammation. Mediators Inflamm 2012;2012:410232.
27. Ma Y, Liu X, Wei Z, Wang X, Xu D, Dai S, Li Y, et al. The expression of a novel anti-inflammatory cytokine IL-35 and its possible significance in childhood asthma. Immunol Lett 2014;162: 11-17.
28. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Ruckert B, Mantel PY, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-1433.
29. Achkova D, Chung FW, Leyhadi JA, Scadding GW, Charlesworth J, Phippard D, Durham S, Shamji MH. Interleukin-35 suppresses allergen-specific Th2 response in patients with grass pollen induced seasonal allergic rhinitis. J Allergy Clin Immunol 2012;129:AB208.
30. Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, et al. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 2012;13: 290-299.
31. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005;5:271-283.
32. Faith A, Singh N, Farooque S, Dimeloe S, Richards DF, Lu H, Roberts D, et al. T cells producing the anti-inflammatory cytokine IL-10 regulate allergen-specific Th2 responses in human airways. Allergy 2012;67:1007-1013.